// Weight Loss
Semaglutide + NAD⁺
Combined GLP-1 + cellular energy support. Pairs appetite control with mitochondrial optimization.
- ✓Combined GLP-1 + NAD⁺ in a single sterile vial
- ✓Pairs appetite control with cellular energy support
- ✓Compounded under USP 797 sterile standards
- ✓Single weekly injection protocol
Starting from
Sign-in required. A licensed physician reviews every prescription before it ships.
Read the full protocol ↓// All formulations
1 formulation available
For orientation only — your physician confirms the final protocol on the pharmacy storefront.
| Option | Size | Price |
|---|---|---|
| Combination injectable | 5 mL vial | $155 |
Compounded by Greenstone Rx · Florida 503A pharmacy
Continue to Pharmacy →// The science
About Semaglutide + NAD⁺
A dual-action compounded injectable that pairs semaglutide (GLP-1 receptor agonist for appetite regulation) with NAD⁺ (mitochondrial coenzyme for cellular energy). Patients on weight-loss protocols sometimes report low energy during titration; this formulation aims to address both signals in one injection.
// How it works
How it works
Two molecules in one injection. The semaglutide arm mimics GLP-1 — slowing stomach emptying and quieting appetite signals so smaller portions feel like enough. The NAD⁺ arm restores a coenzyme central to mitochondrial energy production and DNA repair, addressing the lower-energy weeks that some patients report during weight-loss titration.
// Who it's for
Who it's for
Patients pursuing weight loss who also want metabolic / energy support — particularly anyone who has tried semaglutide alone and felt the low-energy effect during titration. Adults with a BMI over 27 who fit the usual GLP-1 criteria.
// What to expect
Your timeline
Appetite suppression follows the standard semaglutide curve. Some patients report better daytime energy than with semaglutide alone, attributed to the NAD⁺ component. Weekly injection protocol.
// Who should not take this
Who should not take this
Same as semaglutide alone: medullary thyroid carcinoma history, MEN-2 syndrome, pregnancy or planning pregnancy, active pancreatitis, severe gallbladder disease. Discuss with provider if on cancer therapy.
// Typical starting dose
Typical starting dose
A typical starting protocol is one combination injection weekly, dosed to match a semaglutide starter. Your physician will determine the right starting dose during the screening. Suggestions only — your physician reviews and approves the final protocol before any medication ships.
// Ready when you are
Start your prescription.
You'll complete a short health screening on the pharmacy storefront. A licensed physician reviews every order before any medication ships.
Continue to Pharmacy →Compounded by a 503A licensed pharmacy pursuant to a valid prescription. Not an FDA-approved drug. Not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Full disclaimer.